INTEVAC INC false 0001001902 0001001902 2021-02-03 2021-02-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

February 3, 2021

Date of Report (date of earliest event reported)

 

 

INTEVAC, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

State of Delaware   0-26946   94-3125814

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

3560 Bassett Street

Santa Clara, CA 95054

(Address of principal executive offices)

(408) 986-9888

(Registrant’s telephone number, including area code)

N/A

(Former name or former address if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock ($0.001 par value)   IVAC   The Nasdaq Stock Market LLC (Nasdaq) Global Select

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 2.02.

Results of Operations and Financial Condition

On February 3, 2021, Intevac, Inc. issued a press release reporting its financial results for the three months and full year ended January 2, 2021. A copy of the press release issued by the Company concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

The foregoing information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01.

Financial Statements and Exhibits

 

 

(d)

Exhibits

 

99.1

  

Press Release.

104

  

The cover page from this Current Report on Form 8-K, formatted in Inline XBRL


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     

INTEVAC, INC.

Date: February 3, 2021

     

/s/ JAMES MONIZ

     

James Moniz

     

Executive Vice President, Finance and Administration,

     

Chief Financial Officer, Secretary and Treasurer

Exhibit 99.1

 

LOGO

  

3560 Bassett Street, Santa Clara CA 95054        

 

 

 

James Moniz

Chief Financial Officer

(408) 986-9888

      

Claire McAdams

Investor Relations

(530) 265-9899

Intevac Announces Fourth Quarter and Full Year 2020 Financial Results

Santa Clara, Calif.—February 3, 2021—Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the fiscal fourth quarter and year ended January 2, 2021.

Fiscal 2020 Highlights

 

-

Record Photonics revenues of $45.7 million, up 30% year-over-year

 

-

Record sales of system upgrades to our hard disk drive (HDD) customers

 

-

Profitable results, with GAAP EPS of $0.04 and non-GAAP EPS of $0.05 for the year

 

-

Significant cash flow generation, ending fiscal 2020 with $50.4 million in total cash, cash equivalents, restricted cash and investments, an increase of $7.5 million over year-end 2019

“Given the immense challenges faced in 2020, we are pleased to report profitable results and strong cash flow generation for the year,” commented Wendell Blonigan, president and chief executive officer of Intevac. “Our profitable results were driven primarily by our Photonics business, which reported strong growth and a record year as a result of significant development revenues for the IVAS program, the first all-digital solution for the ground soldier. In our Thin-film Equipment (TFE) business, we achieved strong gross margin performance, primarily as a result of record sales of HDD upgrades for both the fourth quarter and full year. While total sales declined year-over-year as a result of COVID-related impacts to our TFE growth initiatives, our combined Photonics and HDD businesses actually grew 5% for the year, exceeding our expectations entering 2020.

“As we look forward, the IVAS program continues to be the primary revenue growth opportunity for Photonics. We expect to transition from the development stage into production over the course of this year, setting the stage for significant growth potential in our Photonics business for 2022 and beyond. In TFE, we expect the investment cycle for HDD media capacity expansions to begin by mid-2021, and accelerate into next year, in support of strong demand for mass-capacity data center storage and growth in high-performance computing. Finally, we believe the multiple evaluation and demo programs in our TFE growth initiatives will contribute to our overall growth story, and continue to support the long-term revenue growth and profitability objectives for Intevac,” concluded Mr. Blonigan.

 

($ Millions, except per share amounts)

   Q4 2020      Q4 2019  
     GAAP Results      Non-GAAP Results      GAAP Results      Non-GAAP Results  

Net Revenues

   $ 28.6      $ 28.6      $ 35.4      $ 35.4  

Operating Income

   $ 1.7      $ 1.7      $ 7.3      $ 7.3  

Net Income

   $ 1.1      $ 1.1      $ 5.2      $ 5.2  

Net Income per Diluted Share

   $ 0.05      $ 0.05      $ 0.22      $ 0.22  
     Year Ended      Year Ended  
     January 2, 2021      December 28, 2019  
     GAAP Results      Non-GAAP Results      GAAP Results      Non-GAAP Results  

Net Revenues

   $ 97.8      $ 97.8      $ 108.9      $ 108.9  

Operating Income

   $ 2.6      $ 2.7      $ 3.9      $ 3.9  

Net Income

   $ 1.1      $ 1.2      $ 1.1      $ 1.2  

Net Income per Diluted Share

   $ 0.04      $ 0.05      $ 0.05      $ 0.05  

Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) restructuring charges; and (2) changes in fair value of contingent consideration liabilities associated with business combinations. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.


Fourth Quarter Fiscal 2020 Summary

Net income for the quarter was $1.1 million, or $0.05 per diluted share, compared to net income of $5.2 million, or $0.22 per diluted share, in the fourth quarter of 2019. Non-GAAP net income for the fourth quarter of 2020 was $1.1 million, or $0.05 per diluted share, compared to non-GAAP net income of $5.2 million, or $0.22 per diluted share, in the fourth quarter of 2019.

Revenues were $28.6 million, including $18.2 million of TFE revenues and $10.4 million of Photonics revenues. TFE revenues consisted of upgrades, spares and service. Photonics revenues included $5.3 million of research and development contracts and $5.1 million of product sales. In the fourth quarter of 2019, revenues were $35.4 million, including $24.4 million of TFE revenues which consisted of two 200 Lean® HDD systems, upgrades, spares and service, and Photonics revenues of $11.1 million, which included $6.2 million of research and development contracts and $4.9 million of product sales.

TFE gross margin was 48.3%, compared to 46.9% in the fourth quarter of 2019 and 43.5% in the third quarter of 2020. The improvement from the fourth quarter of 2019 and the third quarter of 2020 was primarily due to favorable product mix. Photonics gross margin was 27.7%, compared to 45.7% in the fourth quarter of 2019 and 42.8% in the third quarter of 2020. The decline from the fourth quarter of 2019 and the third quarter of 2020 was primarily due to lower margins on research and development contracts. Consolidated gross margin was 40.8%, compared to 46.5% in the fourth quarter of 2019 and 43.1% in the third quarter of 2020.

R&D and SG&A expenses were $10.0 million, compared to $9.2 million in the fourth quarter of 2019 and $9.4 million in the third quarter of 2020.

Order backlog totaled $46.9 million on January 2, 2021, compared to $63.3 million on September 26, 2020 and $92.4 million on December 28, 2019. Backlog at January 2, 2021 and September 26, 2020 did not include any 200 Lean HDD systems. Backlog at December 28, 2019 included two 200 Lean HDD systems.

The Company ended the year with $50.4 million of total cash, cash equivalents, restricted cash and investments and $101.6 million in tangible book value.

Fiscal Year 2020 Summary

Net income was $1.1 million, or $0.04 per diluted share, compared to $1.1 million, or $0.05 per diluted share, for fiscal 2019. Non-GAAP net income was $1.2 million or $0.05 per diluted share, compared to non-GAAP net income of $1.2 million or $0.05 per diluted share for fiscal 2019.

Revenues were $97.8 million, including $52.1 million of TFE revenues and $45.7 million of Photonics revenues, of which $22.9 million was contract R&D revenues, compared to 2019 revenues of $108.9 million, which included $73.7 million of TFE revenues and $35.2 million of Photonics revenues, of which $19.7 million was contract R&D revenues.

TFE gross margin was 43.0%, compared to 37.2% in 2019, while Photonics gross margin was 39.7%, compared to 38.3% in 2019. Consolidated gross margin was 41.4%, compared to 37.5% in 2019. Total R&D and SG&A expenses were $38.0 million, compared to $36.9 million in 2019.

Use of Non-GAAP Financial Measures

Intevac’s non-GAAP results exclude the impact of the following, where applicable: restructuring charges and changes in fair value of contingent consideration liabilities associated with business combinations. A reconciliation of the GAAP and non-GAAP results is provided in the financial tables included in this release.

Management uses non-GAAP results to evaluate the Company’s operating and financial performance in light of business objectives and for planning purposes. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. Intevac believes these measures enhance investors’ ability to review the Company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP.


Conference Call Information

The Company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PST (4:30 p.m. EST). To participate in the teleconference, please call toll-free (877) 407-0989 prior to the start time, and reference meeting number 13714463. For international callers, the dial-in number is +1 (201) 389-0921. You may also listen live via the Internet on the Company’s investor relations website at ir.intevac.com. For those unable to attend live, an archived webcast of the call will be available at ir.intevac.com.

About Intevac

Intevac was founded in 1991 and has two businesses: Thin-film Equipment and Photonics.

In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.

In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital imaging systems for most U.S. military night vision programs.

For more information call 408-986-9888, or visit the Company’s website at www.intevac.com.

200 Lean®, INTEVAC MATRIX®, INTEVAC VERTEX®, ENERGi®, DIAMOND DOG®, DiamondClad®, VERTEX Marathon®, and VERTEX Spectra® are registered trademarks of Intevac, Inc.

Safe Harbor Statement

This press release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Intevac claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” “believes,” “projects,” “expects,” or “anticipates,” and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: impacts related to the COVID-19 global pandemic, customer adoption of our products, future revenue growth potential, and the future financial performance of Intevac. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the Company’s expectations. These risks include, but are not limited to: global economic impacts of COVID-19 including delays in customer evaluations, supply chain constraints and disruptions related to COVID-19, technology risk, challenges achieving customer adoption and revenue growth in Thin-film Equipment markets, and delays in Photonics programs, each of which could have a material impact on our business, our financial results, and the Company’s stock price. These risks and other factors are detailed in the Company’s periodic filings with the U.S. Securities and Exchange Commission.


INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited, in thousands, except percentages and per share amounts)

 

     Three months ended     Year ended  
     January 2,
2021
    December 28,
2019
    January 2,
2021
    December 28,
2019
 

Net revenues

        

TFE

   $ 18,204     $ 24,352     $ 52,128     $ 73,678  

Photonics

     10,372       11,092       45,696       35,207  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     28,576       35,444       97,824       108,885  

Gross profit

     11,669       16,493       40,545       40,868  

Gross margin

        

TFE

     48.3     46.9     43.0     37.2

Photonics

     27.7     45.7     39.7     38.3
  

 

 

   

 

 

   

 

 

   

 

 

 

Consolidated

     40.8     46.5     41.4     37.5

Operating expenses

        

Research and development

     3,499       3,296       14,093       14,309  

Selling, general and administrative

     6,471       5,913       23,897       22,634  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     9,970       9,209       37,990       36,943  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating income

     1,699       7,284       2,555       3,925  

Operating income (loss)

        

TFE

     2,388       5,181       (1,978     1,747  

Photonics

     584       3,321       10,064       6,434  

Corporate

     (1,273     (1,218     (5,531     (4,256
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating income

     1,699       7,284       2,555       3,925  

Interest income and other income (expense), net

     —         133       212       582  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before provision for income taxes

     1,699       7,417       2,767       4,507  

Provision for income taxes

     586       2,215       1,711       3,359  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 1,113     $ 5,202     $ 1,056     $ 1,148  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share

        

Basic

   $ 0.05     $ 0.22     $ 0.04     $ 0.05  

Diluted

   $ 0.05     $ 0.22     $ 0.04     $ 0.05  

Weighted average common shares outstanding

        

Basic

     23,862       23,275       23,669       23,063  

Diluted

     24,456       23,677       24,151       23,340  


INTEVAC, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)

 

     January 2,
2021
    December 28,
2019
 
     (Unaudited)     (see Note)  

ASSETS

  

Current assets

  

Cash, cash equivalents and short-term investments

   $ 44,180     $ 36,487  

Accounts receivable, net

     28,646       28,619  

Inventories

     21,689       24,907  

Prepaid expenses and other current assets

     1,893       1,504  
  

 

 

   

 

 

 

Total current assets

     96,408       91,517  

Long-term investments

     5,388       5,537  

Restricted cash

     787       787  

Property, plant and equipment, net

     11,004       11,598  

Operating lease right-of-use assets

     8,165       10,279  

Intangible assets, net

     —         274  

Other long-term assets

     5,486       6,330  
  

 

 

   

 

 

 

Total assets

   $ 127,238     $ 126,322  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

  

Current liabilities

  

Current operating lease liabilities

   $ 2,853     $ 2,524  

Accounts payable

     4,259       4,199  

Accrued payroll and related liabilities

     7,679       6,488  

Other accrued liabilities

     3,598       3,593  

Customer advances

     33       4,007  
  

 

 

   

 

 

 

Total current liabilities

     18,422       20,811  

Non-current liabilities

  

Non-current operating lease liabilities

     6,803       9,532  

Other long-term liabilities

     457       186  
  

 

 

   

 

 

 

Total non-current liabilities

     7,260       9,718  

Stockholders’ equity

  

Common stock ($0.001 par value)

     24       23  

Additional paid-in capital

     193,173       188,290  

Treasury stock, at cost

     (29,551     (29,158

Accumulated other comprehensive income

     640       424  

Accumulated deficit

     (62,730     (63,786
  

 

 

   

 

 

 

Total stockholders’ equity

     101,556       95,793  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 127,238     $ 126,322  
  

 

 

   

 

 

 

Note: Amounts as of December 28, 2019 are derived from the December 28, 2019 audited consolidated financial statements.


INTEVAC, INC.

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(Unaudited, in thousands, except per share amounts)

 

     Three months ended      Year ended  
     January 2,
2021
     December 28,
2019
     January 2,
2021
     December 28,
2019
 

Non-GAAP Income from Operations

           

Reported operating income (GAAP basis)

   $ 1,699      $ 7,284      $ 2,555      $ 3,925  

Restructuring charges1

     —          —          103        —    

Change in fair value of contingent consideration obligations2

     —          —          —          7  
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP Operating Income

   $ 1,699      $ 7,284      $ 2,658      $ 3,932  
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP Net Income

           

Reported net income (GAAP basis)

   $ 1,113      $ 5,202      $ 1,056      $ 1,148  

Restructuring charges1

     —          —          103        —    

Change in fair value of contingent consideration obligations2

     —          —          —          7  

Income tax effect of non-GAAP adjustments3

     —          —          —          —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP Net Income

   $ 1,113      $ 5,202      $ 1,159      $ 1,155  
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP Net Income Per Diluted Share

           

Reported net income per diluted share (GAAP basis)

   $ 0.05      $ 0.22      $ 0.04      $ 0.05  

Restructuring charges1

   $ —        $ —        $ 0.00      $ —    

Change in fair value of contingent consideration obligations2

   $ —        $ —        $ —        $ 0.00  

Non-GAAP Net Income Per Diluted Share

   $ 0.05      $ 0.22      $ 0.05      $ 0.05  

Weighted average number of diluted shares

     24,456        23,677        24,151        23,340  

 

1 

Results for the year ended January 2, 2021 include severance and other employee-related costs related to a restructuring program.

2 

Results for the year ended December 28, 2019 include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.

3 

The amount represents the estimated income tax effect of the non-GAAP adjustments. The Company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non-GAAP item.